Tecan Group AG (FRA:TEN)

Market Cap	1.92B -38.1%
Revenue (ttm)	970.69M -9.3%
Net Income	67.59M -37.7%
EPS	5.30 -37.2%
Shares Out	n/a
PE Ratio	28.37
Forward PE	19.60
Dividend	3.00 (2.13%)
Ex-Dividend Date	Apr 14, 2025

Volume	n/a
Average Volume	2
Open	225.80
Previous Close	225.80
Day's Range	225.80 - 225.80
52-Week Range	132.30 - 225.80
Beta	n/a
RSI	50.27
Earnings Date	Mar 16, 2026

About Tecan Group AG

Tecan Group AG provides laboratory instruments and solutions in biopharmaceuticals, forensics, and clinical diagnostics in Europe, North America, Asia, and internationally. It operates in two segments, Life Sciences Business and Partnering Business. The company offers liquid handling and automation, microplate readers and washers, software, consumables, NGS reagents, immunoassays and antibodies, and Tecan Labwerx, an end-to-end automation solution. It also provides PARAMIT, a contract design and manufacturing service; Synergence, a customized O...

• Industry: Commercial Physical and Biological Research
• Founded: 1980
• Employees: 3,000
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: TEN

Financial Performance

In 2024, Tecan Group AG's revenue was 934.28 million, a decrease of -13.04% compared to the previous year's 1.07 billion. Earnings were 67.66 million, a decrease of -48.77%.

Financial numbers in CHF